| abstract |
A novel nitrogenous fused bicyclic compound represented by the following general formula [I] or a pharmacologically acceptable salt of the compound. They have excellent SK channel blocking activity and are useful as a medicine. [I] (In the formula, R0 represents hydrogen, halogeno, etc.; R1 represents a group represented by the formula (a) or (b) A represents a group represented by the formula (X) or (Y) D1, D2, and D3 each represents N or CH; R2 represents halogeno, optionally halogenated lower alkyl, etc.; R3 represents hydrogen or lower alkyl; and Q represents lower alkylene.) |